Acelot, Inc is a development stage biopharmaceutical company based in Santa Barbara, CA, dedicated to preventing and treating neurodegenerative disorders through a unified approach that combines machine learning and in vitro assays to identify small molecules targeting toxic proteins.
With a team of experienced professionals in biotech, computer science, medicinal chemistry, preclinical research, molecular biology, and data science, Acelot is at the forefront of innovative research and drug discovery in the field of neurodegeneration.
Generated from the website